Alkermes(us:ALKS)
29.67
-0.13%
Updated on 2024-12-23
Open:29.63
Close:29.67
High:29.81
Low:29.18
Pre Close:29.71
Volume:493746.00
Amount:14.54M
Turnover:0.31%
Shares:161.80M
MarketCap:4.80B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 16 | 105167 | 0.06% | 1 | 7 | 2 |
| 2024-03-31 | 348 | 173838379 | 102.75% | 56 | 111 | 140 |
| 2023-12-31 | 358 | 175537519 | 105.12% | 56 | 122 | 141 |
| 2023-09-30 | 331 | 161984529 | 97.16% | 51 | 140 | 108 |
| 2023-06-30 | 314 | 159026631 | 95.51% | 55 | 101 | 119 |
| 2023-03-31 | 296 | 160021646 | 96.36% | 34 | 90 | 126 |
| 2022-12-31 | 307 | 161601347 | 98.31% | 46 | 102 | 119 |
| 2022-09-30 | 303 | 158014510 | 96.17% | 36 | 117 | 111 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Blackrock Inc. | 29107548 | 17.55% | -60933 | -0.21% |
| 2024-06-30 | Vanguard Group Inc | 19999872 | 12.06% | -161308 | -0.80% |
| 2024-06-30 | Wellington Management Group Llp | 14354752 | 8.65% | -537608 | -3.61% |
| 2024-06-30 | Price T Rowe Associates Inc /Md/ | 11012312 | 6.64% | 2686056 | 32.26% |
| 2024-06-30 | State Street Corp | 9215058 | 5.55% | 211145 | 2.35% |
| 2024-06-30 | Rtw Investments, Lp | 7056988 | 4.25% | 1002708 | 16.56% |
| 2024-06-30 | Pacer Advisors, Inc. | 5640642 | 3.40% | 1362079 | 31.84% |
| 2024-06-30 | Renaissance Technologies Llc | 5483831 | 3.31% | -403320 | -6.85% |
| 2024-06-30 | Baker Bros. Advisors Lp | 4181751 | 2.52% | 4181751 | |
| 2024-06-30 | Geode Capital Management, Llc | 3933964 | 2.37% | 191193 | 5.11% |
About
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.
Address:Connaught House,1 Burlington Road
Website:http://www.alkermes.com
Market Movers